Immunotherapy vaccines are the only effective treatment that works from the cause or origin of the problem, changing the course of allergic disease and in many cases preventing the development of asthma, so the WHO considers allergen immunotherapy or vaccines as the only effective treatment that treats the cause of allergic disease.
The treatment comprises administering to the patient increasing doses of the allergen allergy causing substance or its allergic reaction, starting with a first phase of initiation until a maximal dose or maintenance dose, which is administered over a long period of time.
The effectiveness of these treatments is observed in the long term and it is recommended vaccination period between 3 and 5 years.
Angouleme Laboratory makes available a wide range of specialist treatments classified according to the route of administration:
- Subcutaneous. Subcutaneous immunotherapy
- Sublingual. Sublingual immunotherapy
Subcutaneous immunotherapy involves the subcutaneous administration by injections of the allergen (mites, pollens, molds, epithelia …), causing the allergic process. This administration is in increasing doses in two phases: a first phase of initiation with a variable length depending on the treatment you choose your specialist treatment and subsequently develops a second maintenance phase in which the administration is usually done monthly by a period of 3-5 years.
Although immunotherapy treatment is long term treatment, the improvement of the symptoms of allergic disease are manifested earlier.
Sublingual immunotherapy involves the administration of the allergen through the sublingual mucosa.
This type of treatment required for the proper performance of the patient, since the administration is performed daily at the household level over a period of 3-5 years.